Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization.
Jin W
,
Brown S
,
Roche JP
,
Hsieh C
,
Celver JP
,
Kovoor A
,
Chavkin C
,
Mackie K
.
???displayArticle.abstract???
Desensitization of cannabinoid receptor signaling by a G-protein coupled receptor kinase (GRK) was examined using the Xenopus oocyte expression system. Application of a CB1 agonist, WIN 55,212-2, evoked a concentration-dependent increase in K+ conductance (Kir3) in oocytes coexpressing rat CB1 with the G-protein-gated, inwardly rectifying K+ channels Kir3.1 and Kir3.4. Desensitization was slight during continuous agonist application in the absence of GRK and arrestin. However, coexpression of GRK3 and beta-arrestin 2 (beta-arr2) caused profound homologous CB1 receptor desensitization, supporting the hypothesis that GRK3 and beta-arr2 effectively produce CB1 receptor desensitization. To identify the regions of the CB1 receptor responsible for GRK3- and beta-arr2-mediated desensitization, we constructed several CB1 receptor mutants. Truncation of the C-terminal tail of CB1 receptor at residue 418 (Delta418) almost completely abolished desensitization but did not affect agonist activation of Kir3. In contrast, truncation at residues 439 and 460 did not significantly affect GRK3- and beta-arr2-dependent desensitization. A deletion mutant (Delta418-439) did not desensitize, indicating that residues within this region are important for GRK3- and beta-arr2-mediated desensitization. Phosphorylation in this region was likely involved in desensitization, because mutation of either of two putative phosphorylation sites (S426A or S430A) significantly attenuated desensitization. CB1 receptors rapidly internalize after activation by agonist. Phosphorylation of S426 or S430 was not necessary for internalization, because the S426A/S430A CB1 mutant internalized when stably expressed in AtT20 cells. These studies establish that CB1 desensitization can be regulated by a GRK and that different receptor domains are involved in GRK- and beta-arrestin-dependent desensitization and CB1 internalization.
Abood,
Neurobiology of marijuana abuse.
1992, Pubmed
Abood,
Neurobiology of marijuana abuse.
1992,
Pubmed
Appleyard,
Agonist-induced phosphorylation of the kappa-opioid receptor.
1997,
Pubmed
Bouvier,
Removal of phosphorylation sites from the beta 2-adrenergic receptor delays onset of agonist-promoted desensitization.
1988,
Pubmed
Chen,
Beta-adrenergic receptor kinase. Agonist-dependent receptor binding promotes kinase activation.
1993,
Pubmed
Devane,
Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
1992,
Pubmed
Dewey,
Cannabinoid pharmacology.
1986,
Pubmed
Di Marzo,
Formation and inactivation of endogenous cannabinoid anandamide in central neurons.
1994,
Pubmed
Dohlman,
The multiple membrane spanning topography of the beta 2-adrenergic receptor. Localization of the sites of binding, glycosylation, and regulatory phosphorylation by limited proteolysis.
1987,
Pubmed
Freedman,
Desensitization of G protein-coupled receptors.
1996,
Pubmed
Garcia,
Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor.
1998,
Pubmed
Hamill,
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.
1981,
Pubmed
Henry,
Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes.
1995,
Pubmed
,
Xenbase
Ho,
Site-directed mutagenesis by overlap extension using the polymerase chain reaction.
1989,
Pubmed
Hsieh,
Internalization and recycling of the CB1 cannabinoid receptor.
1999,
Pubmed
Inglese,
Structure and mechanism of the G protein-coupled receptor kinases.
1993,
Pubmed
Kovoor,
Agonist-induced desensitization of the mu opioid receptor-coupled potassium channel (GIRK1).
1995,
Pubmed
,
Xenbase
Kovoor,
Mu and delta opioid receptors are differentially desensitized by the coexpression of beta-adrenergic receptor kinase 2 and beta-arrestin 2 in xenopus oocytes.
1997,
Pubmed
,
Xenbase
Krupnick,
The role of receptor kinases and arrestins in G protein-coupled receptor regulation.
1998,
Pubmed
Liggett,
Sites in the third intracellular loop of the alpha 2A-adrenergic receptor confer short term agonist-promoted desensitization. Evidence for a receptor kinase-mediated mechanism.
1992,
Pubmed
Lin,
Clathrin-mediated endocytosis of the beta-adrenergic receptor is regulated by phosphorylation/dephosphorylation of beta-arrestin1.
1997,
Pubmed
Mackie,
Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor.
1995,
Pubmed
Martin,
Progress toward understanding the cannabinoid receptor and its second messenger systems.
1994,
Pubmed
Matsuda,
Molecular aspects of cannabinoid receptors.
1997,
Pubmed
Matsuda,
Structure of a cannabinoid receptor and functional expression of the cloned cDNA.
1990,
Pubmed
Pei,
Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C.
1995,
Pubmed
Pertwee,
Pharmacology of cannabinoid CB1 and CB2 receptors.
1997,
Pubmed
Pertwee,
The evidence for the existence of cannabinoid receptors.
1993,
Pubmed
Raynor,
Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor.
1994,
Pubmed
Sim,
Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.
1996,
Pubmed
Stella,
A second endogenous cannabinoid that modulates long-term potentiation.
1997,
Pubmed
Vu,
Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.
1991,
Pubmed
,
Xenbase
Zhang,
Molecular mechanisms of G protein-coupled receptor signaling: role of G protein-coupled receptor kinases and arrestins in receptor desensitization and resensitization.
1997,
Pubmed
